Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Witzleben

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Experimental and Molecular Pathology|February 1, 1972
Hepatic ultrastructural effects of cholic acid overloadC L Witzleben
Gastroenterology|March 1, 1972
Mechanism of cholestasisC L Witzleben
The Journal of Pediatrics|November 1, 1970
Congenital heart disease with sudden onset of convulsions and comaC L Witzleben, P Dodge
Human Pathology|April 1, 1989
Perinatal hemochromatosis: entity or end result?C L Witzleben, A Uri
Archives of Pathology & Laboratory Medicine|June 1, 1978
Foamy myocardial transformation of infancy: 'lipid' or 'histiocytoid' myocardiopathyC L Witzleben, M Pinto
The American Journal of Pathology|September 1, 1973
Bilirubin as a cholestatic agent. II. Effect of variable doses of bilirubin on the severity of manganese-bilirubin cholestasisW Boyce, C L Witzleben
Journal of Medical Education|October 1, 1973
Clinical practitioners as a resource for curriculum planningW J Oetgen, C L Witzleben
Human Pathology|August 1, 1982
"Nephronophthisis-congenital hepatic fibrosis": an additional hepatorenal disorderC L Witzleben, A R Sharp
The American Journal of Gastroenterology|December 1, 1988
Neonatal hemochromatosisC L Witzleben, A K Uri
Archives of Pathology|September 1, 1975
Bilirubin as a cholestatic agent. III. Prevention of bilirubin-related cholestasis by sulfobromophthaleinC L Witzleben, W H Boyce
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Experimental and Molecular Pathology|February 1, 1972
Hepatic ultrastructural effects of cholic acid overloadC L Witzleben
Gastroenterology|March 1, 1972
Mechanism of cholestasisC L Witzleben
The Journal of Pediatrics|November 1, 1970
Congenital heart disease with sudden onset of convulsions and comaC L Witzleben, P Dodge
Human Pathology|April 1, 1989
Perinatal hemochromatosis: entity or end result?C L Witzleben, A Uri
Archives of Pathology & Laboratory Medicine|June 1, 1978
Foamy myocardial transformation of infancy: 'lipid' or 'histiocytoid' myocardiopathyC L Witzleben, M Pinto
The American Journal of Pathology|September 1, 1973
Bilirubin as a cholestatic agent. II. Effect of variable doses of bilirubin on the severity of manganese-bilirubin cholestasisW Boyce, C L Witzleben
Journal of Medical Education|October 1, 1973
Clinical practitioners as a resource for curriculum planningW J Oetgen, C L Witzleben
Human Pathology|August 1, 1982
"Nephronophthisis-congenital hepatic fibrosis": an additional hepatorenal disorderC L Witzleben, A R Sharp
The American Journal of Gastroenterology|December 1, 1988
Neonatal hemochromatosisC L Witzleben, A K Uri
Archives of Pathology|September 1, 1975
Bilirubin as a cholestatic agent. III. Prevention of bilirubin-related cholestasis by sulfobromophthaleinC L Witzleben, W H Boyce
Pageof 5